Tango Therapeutics (TNGX) Leases (2020 - 2025)
Tango Therapeutics (TNGX) has 6 years of Leases data on record, last reported at $35.6 million in Q4 2025.
- For Q4 2025, Leases fell 9.87% year-over-year to $35.6 million; the TTM value through Dec 2025 reached $35.6 million, down 9.87%, while the annual FY2025 figure was $35.6 million, 9.87% down from the prior year.
- Leases reached $35.6 million in Q4 2025 per TNGX's latest filing, down from $36.6 million in the prior quarter.
- Across five years, Leases topped out at $47.8 million in Q3 2022 and bottomed at $520000.0 in Q2 2022.
- Average Leases over 5 years is $33.1 million, with a median of $40.1 million recorded in 2024.
- Peak YoY movement for Leases: crashed 83.28% in 2021, then skyrocketed 8616.35% in 2023.
- A 5-year view of Leases shows it stood at $1.3 million in 2021, then soared by 3640.03% to $46.9 million in 2022, then fell by 7.25% to $43.5 million in 2023, then fell by 9.2% to $39.5 million in 2024, then decreased by 9.87% to $35.6 million in 2025.
- Per Business Quant database, its latest 3 readings for Leases were $35.6 million in Q4 2025, $36.6 million in Q3 2025, and $37.6 million in Q2 2025.